Correlation Engine 2.0
Clear Search sequence regions

  • acetamides (2)
  • and disease (1)
  • bone marrow (2)
  • brucella (5)
  • brucella abortus (2)
  • brucellosis (1)
  • epoprostenol (2)
  • epoprostenol (7)
  • F actin (1)
  • female (1)
  • free (1)
  • humans (1)
  • IL 10 (1)
  • lipid (1)
  • macrophages (7)
  • MAPK (1)
  • mice (3)
  • P 450 (2)
  • p38α (1)
  • pathogen (1)
  • pgi2 receptor (3)
  • PTGIR (2)
  • PTGIS (1)
  • Ptgs2 (1)
  • pyrazines (2)
  • selexipag (3)
  • signal (1)
  • spleen (1)
  • Sizes of these terms reflect their relevance to your search.

    To date, the implications of prostaglandin I2 (PGI2), a prominent lipid mediator for modulation of immune responses, has not been clearly understood in Brucella infection. In this study, we found that cyclooxygenase-2 (COX-2) was significantly expressed in both infected bone marrow-derived macrophages (BMMs) and RAW 264.7 cells. Prostaglandin I2 synthase (PTGIS) expression was not significantly changed, and PGI2receptor (PTGIR) expression was downregulated in BMMs but upregulated in RAW 264.7 macrophages at late infection. Here, we presented that PGI2, a COX-derived metabolite, was produced by macrophages during Brucella infection and its production was regulated by COX-2 and IL-10. We suggested that PGI2 and selexipag, a potent PGI2 analogue, inhibited Brucella internalization through IP signaling which led to down-regulation of F-actin polymerization and p38α MAPK activity. Administration with selexipag suppressed immune responses and resulted in a notable reduction in bacterial burden in spleen of Brucella-challenged mice. Taken together, our study is the first to characterize PGI2 synthesis and its effect in evasion strategy of macrophages against Brucella infection. Copyright © 2020 Elsevier Ltd. All rights reserved.


    Son Hai Vu, Alisha Wehdnesday Bernardo Reyes, Tran Xuan Ngoc Huy, Wongi Min, Hu Jang Lee, Hyun-Jin Kim, John Hwa Lee, Suk Kim. Prostaglandin I2 (PGI2) inhibits Brucella abortus internalization in macrophages via PGI2 receptor signaling, and its analogue affects immune response and disease outcome in mice. Developmental and comparative immunology. 2021 Feb;115:103902

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33091457

    View Full Text